You are here
L2 DIAGNOSTICS LLC
UEI: GKA7VH5LFR25
# of Employees: 15
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
IGF OT IGF Topic Phase I SBIR Predictive Biomarkers of Adverse Reactions to Prostate Cancer Radiotherapy
Amount: $271,237.00Not Available
SBIRPhase I2015Department of Health and Human Services National Institutes of Health -
Therapeutic Inhibition of MIF in Type 1 Diabetes
Amount: $297,302.00DESCRIPTION provided by applicant The long term product goal of this project is a small molecule therapeutic to prevent or treat Type diabetes T D Our objective is to reduce the inflammatory r ...
SBIRPhase I2015Department of Health and Human Services National Institutes of Health -
Targeted Inactivation of the CCR5 HIV Coreceptor with Peptide Nucleic Acids
Amount: $250,298.00DESCRIPTION (provided by applicant): Over 34 million people are currently living with HIV/AIDS. Combination antiviral therapies have significantly reduced the morbidity and mortality of the disease; h ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
Sterculic Acid Analogs to Inhibit Macular Degeneration
Amount: $224,700.00ABSTRACT The long-term product goal of this project is a small molecule therapeutic for choroidal neovascularization (CNV, the hallmark of wet age-related macular degradation), an abnormal growth o ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
Measurement of Beta Cell Death in Diabetes
Amount: $1,348,103.00DESCRIPTION provided by applicant All forms of diabetes are characterized by the death of insulin producing cells In Type diabetes T D this leads to the reliance on exogenous insulin for sur ...
STTRPhase II2014Department of Health and Human Services National Institutes of Health -
A serologic assay to measure successful Lyme borreliosis antibiotic therapy
Amount: $2,642,728.00DESCRIPTION provided by applicant Lyme disease LD caused by the Ixodes tick borne spirochete Borrelia burgdorferi Bb is the most common vector borne disease in the United States Despite publi ...
SBIRPhase II2014Department of Health and Human Services National Institutes of Health -
Diagnostic Assays for early Lyme Borreliosis using in-vivo expressed antigens
Amount: $1,655,122.00DESCRIPTION provided by applicant Current testing for Lyme disease is suboptimal because it requires two assay platforms including one with subjective interpretation of results and because it has ...
SBIRPhase II2014Department of Health and Human Services National Institutes of Health -
A Multivalent Lyme Disease Vaccine Targeting Tick-Host-Pathogen Interactions
Amount: $599,996.00DESCRIPTION provided by applicant This proposal seeks to develop a novel vaccine against Lyme disease by targeting Ixodes scapularis proteins critical for Borrelia burgdorferi transmission from ...
STTRPhase I2014Department of Health and Human Services National Institutes of Health -
RNA Detection as an Improved Diagnostic Assay for Human Leptospirosis
Amount: $600,000.00DESCRIPTION provided by applicant Leptospirosis a zoonotic disease is an important public health problem worldwide It is caused by spirochete bacteria belonging to nine species and more than ...
STTRPhase I2014Department of Health and Human Services National Institutes of Health -
Small Molecule Antiviral Agents Against Flaviviruses
Amount: $996,931.00Flaviviruses, and dengue viruses in particular, are significant human pathogens. No vaccine or specific therapeutic agent is available against West Nile and dengue viruses. Our goal is to develop pe ...
SBIRPhase II2013Department of Defense Army
